treatment innovation in dlbcl: real-world insight on integrating antibodies and cellular therapy
Published 2 years ago • 338 plays • Length 56:44Download video MP4
Download video MP3
Similar videos
-
1:24:16
perspectives on novel antibody platforms in dlbcl
-
1:26:18
new models for nhl care: innovative therapy in fl and dlbcl
-
35:09
moving beyond conventional care for dlbcl
-
1:19:12
the next phase of targeted therapy in mcl and dlbcl
-
35:36
conversations on the new wave of innovative therapy in follicular lymphoma
-
1:41
real-world efficacy of tafasitamab lenalidomide in r/r dlbcl & the importance of patient selection
-
59:01
reaping the rewards of innovative care in cll: from targeted strategies to cellular therapy
-
1:30
bispecific antibodies for r/r aggressive b-cell lymphomas
-
1:19
real-world outcomes of liso-cel therapy in r/r dlbcl
-
3:00
what is diffuse large b-cell lymphoma (dlbcl)?
-
1:38
using pet to predict failure to salvage therapy in patients with dlbcl
-
3:10
clinical trials and research for diffuse large b-cell lymphoma
-
1:12:28
perspectives on innovative treatment for b-cell malignancies
-
3:39
an expert review of dlbcl research and treatment advances
-
48:43
taking the next steps with next-generation btki in cll, mcl, and dlbcl
-
23:45
innovative advances in diffuse large b-cell lymphoma: new and emerging treatment options
-
2:08
the current and future role of bispecifics in r/r dlbcl: epcoritamab, glofitamab & more
-
2:39
the role of bispecific antibodies in the treatment landscape for r/r dlbcl
-
4:39
treatment alternatives to chemotherapy in r/r dlbcl